What does Dermata Therapeutics, Inc. do?
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the…
What is Dermata Therapeutics, Inc.'s P/E and P/B ratio?
Dermata Therapeutics, Inc. has a P/E ratio of -0.2 and a P/B ratio of 1.11.
What is Dermata Therapeutics, Inc.'s debt-to-equity ratio?
Dermata Therapeutics, Inc. has a debt-to-equity ratio of 0.00.
How much does Dermata Therapeutics, Inc. owe compared with what it owns?
Dermata Therapeutics, Inc. owes $0.34 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Dermata Therapeutics, Inc.'s Positivity rank?
Dermata Therapeutics, Inc. is ranked #1,118 of 6,775 companies globally and #208 of 3,999 in United States on PositoAI, with a Positivity Score of 23,295.
Does Dermata Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Dermata Therapeutics, Inc. has no active red flags. It has 1 yellow flag (PosiYellow stress signals, 2/10 points): Change of auditor (8-K Item 4.01).
Where can I read the latest news about Dermata Therapeutics, Inc.?
Recent headlines about Dermata Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Dermata Therapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Dermata Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.